Clinical Trial Update: Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating oral lipid ingestion in relation to ovarian androgen secretion in Polycystic Ovary Syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: Indiana University | Conditions: Polycystic Ovary Syndrome | Phase 1 | Status: TERMINATED